Purchase Order DOCEA133C07SU1176

This is a $14,024.50 firm fixed price purchase order awarded by the National Oceanic and Atmospheric Administration (NOAA), a civilian agency within the U.S. Department of Commerce, to Phytoxigene Inc., a foreign-owned, self-certified small disadvantaged business based in Akron, Ohio. The contract is for the purchase of cyanobacteria toxin kits to support NOAA's ocean monitoring programs and research related to harmful algal blooms. This award is not associated with a larger contract vehicle and...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Oceanic and Atmospheric Administration (NOAA) to Giner Inc., a small business research and development firm based in Auburndale, Massachusetts. The $94,996 firm-fixed-price contract is for a project titled "Rapid and Low-Cost Field Toxin Analysis to Monitor Harmful Algal Blooms." This SBIR contract is part of NOAA's Technology Partnerships Office under the Office of Atmospheric Research in...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of BREVIBLOC 2,000 MG/100 ML BAG 100ML, a pharmaceutical product. The delivery order is valued at $9,995.45 and has a firm fixed price. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product, with a ceiling value of $1,705.58. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of September 24, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug...

This federal contract award, with a ceiling value of $1,030.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of BREVIBLOC 2,500 MG/250 ML BAG 250ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 3, 2024. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, has...

This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract is for the provision of 4563969956 - BRIVIACT 50 MG TABLET 60S, a specialty pharmaceutical product, with a ceiling value of $3,172.86 and a period of performance through March 15, 2024. The contract is not set-aside and is part of a larger indefinite delivery contract (IDC)...

Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,711.16 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 4563501675 BREVIBLOC 2,500 MG/250 ML BAG 250ML. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 and running through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BRIVIACT 100 MG TABLET 60S. The contract has a potential value of $2,818.60 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not associated with any set-aside program. The company has an extensive history of federal contract awards from DLA...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the provision of 4565148091 BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product, with a ceiling value of $1,705.58 and a performance period ending on July 16, 2024. The contract is a firm fixed-price type and does not have a set-aside designation. AmerisourceBergen Drug Corp is a major supplier of...

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $2,550.48 and a completion date of December 19, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...